About Diopsys
Diopsys is a company based in Montville (United States) founded in 2002 was acquired by LumiThera in November 2021.. Diopsys has raised $1.05 million across 1 funding round from investors including LumiThera. The company has 31 employees as of December 31, 2021. Diopsys offers products and services including NOVA Vision Testing System, VEP, and ERG. Diopsys operates in a competitive market with competitors including Sensimed, i-Optics, Azul Optics, Oxymap and Bioptigen, among others.
- Headquarter Montville, United States
- Employees 31 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diopsys, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diopsys
Diopsys offers a comprehensive portfolio of products and services, including NOVA Vision Testing System, VEP, and ERG. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for advanced vision testing and diagnostics in healthcare settings.
Technology for visual evoked potential testing in select countries.
Electroretinography device for eye function assessment outside the US.
Unlock access to complete
Funding Insights of Diopsys
Diopsys has successfully raised a total of $1.05M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.05 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.0M
-
First Round
First Round
(17 Oct 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Seed - Diopsys | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diopsys
Diopsys has secured backing from 1 investor. Prominent investors backing the company include LumiThera. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Photobiomodulation treatments for ocular diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diopsys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diopsys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diopsys Comparisons
Competitors of Diopsys
Diopsys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, i-Optics, Azul Optics, Oxymap and Bioptigen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| domain | founded_year | HQ Location |
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
|
|
| domain | founded_year | HQ Location |
Device for assessing the eye health against damaging light
|
|
| domain | founded_year | HQ Location |
Retinal Imaging technology to assess retinal oxygen saturation and vessel width
|
|
| domain | founded_year | HQ Location |
Spectral domain OCT devices for ophthalmic imaging are developed.
|
|
| domain | founded_year | HQ Location |
Portable technologies for multifocal eye corrections before surgeries are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diopsys
Frequently Asked Questions about Diopsys
When was Diopsys founded?
Diopsys was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Where is Diopsys located?
Diopsys is headquartered in Montville, United States. It is registered at Montville, New Jersey, United States.
Is Diopsys a funded company?
Diopsys is a funded company, having raised a total of $1.05M across 1 funding round to date. The company's 1st funding round was a Seed of $1.05M, raised on Oct 17, 2019.
How many employees does Diopsys have?
As of Dec 31, 2021, the latest employee count at Diopsys is 31.
What does Diopsys do?
Diopsys is a provider of non-invasive office-based visual electrophysiology medical devices that help ophthalmologists and optometrists analyze the entire visual pathway for visual and neuro-visual disorders. The company provides both Visual Evoked Potential (VEP) and Electroretinography (ERG) vision testing technology. Diopsys, Inc.s medical devices include the Diopsys NOVA and Diopsys ARGOS ERG and VEP Vision Testing System product series and the Enfant Pediatric VEP Vision Testing System.
Who are the top competitors of Diopsys?
Diopsys's top competitors include 2EyesVision, Sensimed and Azul Optics.
What products or services does Diopsys offer?
Diopsys offers NOVA Vision Testing System, VEP, and ERG.
Who are Diopsys's investors?
Diopsys has 1 investor. Key investors include LumiThera.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.